[HTML][HTML] Nanotechnology approaches for enhanced CNS drug delivery in the management of schizophrenia
R Rajendran, KN Menon, SC Nair - Advanced Pharmaceutical …, 2022 - ncbi.nlm.nih.gov
Schizophrenia is a neuropsychiatric disorder mainly affecting the central nervous system
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia
R Rajendran, KN Menon, SC Nair - Advanced Pharmaceutical …, 2021 - apb.tbzmed.ac.ir
Schizophrenia is a neuropsychiatric disorder mainly affecting the central nervous system
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
[PDF][PDF] Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia
R Rajendran, KN Menon, SC Nair - 2022 - sid.ir
Schizophrenia is a neuropsychiatric disorder mainly affecting the central nervous system
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia.
R Rajendran, KN Menon, SC Nair - Advanced Pharmaceutical …, 2021 - europepmc.org
Schizophrenia is a neuropsychiatric disorder mainly affecting the central nervous system
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia.
R Rajendran, KN Menon… - Advanced Pharmaceutical …, 2022 - search.ebscohost.com
Schizophrenia is a neuropsychiatric disorder mainly affecting the central nervous system
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia
R Rajendran, KN Menon… - Advanced Pharmaceutical …, 2022 - search.proquest.com
Abstract According to the World Health Organization (WHO), about 20 million people are
affected with schizophrenia worldwide. 1 People with schizophrenia die at an early life 3-4 …
affected with schizophrenia worldwide. 1 People with schizophrenia die at an early life 3-4 …
Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia
R Rajendran, KN Menon… - Advanced …, 2022 - pubmed.ncbi.nlm.nih.gov
Schizophrenia is a neuropsychiatric disorder mainly affecting the central nervous system
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia
R Rajendran, MK Neelakandha, NS Chandrasekharan - 2022 - sid.ir
Schizophrenia is a neuropsychiatric disorder mainly affecting the central nervous system
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia
R Rajendran, KN Menon, SC Nair - Advanced Pharmaceutical …, 2021 - apb.tbzmed.ac.ir
Schizophrenia is a neuropsychiatric disorder mainly affecting the central nervous system
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …
(CNS), presented with auditory and visual hallucinations, delusion and withdrawal from …